CJC-1295

CJC-1295 with DAC
CJC-1295 with DAC (Drug Affinity Complex) is a long-acting synthetic peptide widely studied in endocrine and metabolic research. The addition of the DAC component allows the peptide to bind to circulating proteins, significantly extending its stability and duration of activity in experimental models.

Research Overview
CJC-1295 with DAC is primarily investigated for its interaction with growth hormone–releasing pathways. In controlled laboratory environments, researchers study its role in long-term signaling mechanisms related to growth hormone dynamics, metabolic regulation, and recovery-associated processes.

Key Research Areas

• Growth hormone signaling pathways
• Endocrine system modulation
• Metabolic regulation studies
• Cellular recovery and adaptation models
• Long-acting peptide signaling research

Why CJC-1295 with DAC Is of Interest in Research
What distinguishes CJC-1295 with DAC is its prolonged activity profile compared to non-DAC variants. This makes it particularly valuable for research requiring sustained pathway activation and long-term observation of hormonal and metabolic responses in experimental settings.

Product Composition

• Peptide: CJC-1295 with DAC
• Form: Lyophilized powder
• Purity: High-purity, laboratory-verified
• Testing: Independently analyzed for identity and purity

Quality & Verification
At EuroLab-Certified Peptides, CJC-1295 with DAC is produced under strict quality control standards. Each batch undergoes comprehensive third-party laboratory testing to ensure exceptional purity, consistency, and reliability — supporting precise and reproducible research outcomes.

Important Notice
This product is supplied strictly for research and laboratory use only.

Not for human or veterinary consumption.